There are 68 papers on postprandial blood glucose in aging research: 43 trials and 11 observational studies in people, 6 in animals, 7 reviews.
68 papers study it80 more mention it32 findings
9 new papers in 30 daysSee all 148 papers on postprandial blood glucose
“A correlation between postprandial glycemia and GIFC after 12 weeks was detected (r = 0.37; p = 0.04)”
- Human trial43
- Humans11
- Animals6
Interventions
10Acarbose
downin humans13downin mice2
15 studies
Acarbose
downin humans13downin mice2
Acarbose decreases postprandial blood glucose in type 1 diabetes patients, 90 minutes after meal.
Human trialin type 1 diabetes patients, 90 minutes after mealn = 20
Acarbose decreases postprandial blood glucose in humans (added to diet alone, sulfonylurea, biguanide or insulin).
Human trialadded to diet alone, sulfonylurea, biguanide or insulin1 year
Acarbose decreases postprandial blood glucose in patients with non-insulin-dependent diabetes mellitus (approximately 56 mg/dL reduction vs 13 mg/dL with placebo).
Human trialin patients with non-insulin-dependent diabetes mellitus200 mg TID24 weeks
Acarbose decreases postprandial blood glucose in humans (added to sulfonylureas in type 2 diabetes; compared with placebo).
Human trialadded to sulfonylureas in type 2 diabetes; compared with placebothree monthsn = 14
Acarbose decreases postprandial blood glucose in humans.
Human trialType 1 diabetes; intensified insulin therapy; abandonment of the 30-minute injection-eating interval; compared with pretreatment while observing the interval100 mg three times daily3 daysn = 7
Acarbose decreases postprandial blood glucose in humans (co-treated with sulfonylureas).
Human trialco-treated with sulfonylureas100 mg tablets100 mg tid12 weeks
Acarbose decreases postprandial blood glucose in humans (compared with baseline values).
Human trialcompared with baseline values4 monthsn = 15
Acarbose decreases postprandial blood glucose in humans with fixed 75 g sucrose load (161, 145, 120 and 102 mg/dl at 0, 50, 100 and 200 mg acarbose).
Human trialwith fixed 75 g sucrose load0, 50, 100 and 200 mg acarbosen = 4
Acarbose decreases postprandial blood glucose in humans (healthy subjects receiving fiber-free formula diets) (Postprandial glucose AUC: 1.836 to -504 mg/dl X min in Study 1; 587 to -302 mg/dl X min in Study 2).
Human trialhealthy subjects receiving fiber-free formula diets10 to 14 days
Acarbose decreases postprandial blood glucose in humans (added to glibenclamide 15 mg/day).
Human trialadded to glibenclamide 15 mg/day3 X 100 mg dailythree weeksn = 9
All 15Fewer
Chenopodium quinoa
downin humans1
1 study
Chenopodium quinoa
downin humans1
Chenopodium quinoa decreases postprandial blood glucose in humans (4.57 ± 2.7 mmol/L vs 2.2 ± 2.8 mmol/L).
Human trial14 weeksn = 60
Chenopodium quinoa decreases postprandial blood glucose in humans (early-stage T2DM) (4.57 ± 2.7 mmol/L vs 2.2 ± 2.8 mmol/L, P <0.001).
Human trialearly-stage T2DMn = 60
Fractionated soy-casein composite peptides
downin humans1downin mice1
1 study
Fractionated soy-casein composite peptides
downin humans1downin mice1
Fractionated soy-casein composite peptides decrease postprandial blood glucose in humans (postprandial).
Human trialpostprandialfractionated soy-casein composite peptides
Fractionated soy-casein composite peptides decrease postprandial blood glucose in mice (postprandial).
Animalspostprandialfractionated soy-casein composite peptides
Exercise
downin humans1
1 study
Exercise
downin humans1
Exercise decreases postprandial blood glucose in humans (type 2 diabetes mellitus; compared with control) (Hedges' g = -1.82; SE = 0.23; P < 0.05).
Reviewtype 2 diabetes mellitus; compared with control
Dapagliflozin + glimepiride + metformin
downin humans1
1 study
Dapagliflozin + glimepiride + metformin
downin humans1
Dapagliflozin + glimepiride + metformin is linked with lower postprandial blood glucose in humans (-71.11±1.24 mg/dL).
Humans12±2 weeksn = 3,770
Auricular acupressure
downin humans1
1 study
Auricular acupressure
downin humans1
Auricular acupressure decreases postprandial blood glucose in humans.
Human trial8 weeksn = 42
Pilates
downin humans1
1 study
Pilates
downin humans1
Pilates decrease postprandial blood glucose in humans (older women with type 2 diabetes) (246.1 ± 58.5 vs. 207.6 ± 49.1 mg·dl at 12 weeks).
Human trialolder women with type 2 diabetes60 minutes, 3 times per week12 weeksfemales
Baicalein + acarbose
downin mice1
1 study
Baicalein + acarbose
downin mice1
Baicalein + acarbose decreases postprandial blood glucose in mice (combined treatment after sucrose loading) (synergistic; comparable to 8 mg/kg acarbose).
Animalscombined treatment after sucrose loading80 mg/kg baicalein and 1 mg/kg acarbose
Baicalein
downin mice1
1 study
Baicalein
downin mice1
Baicalein decreases postprandial blood glucose in mice after sucrose loading; dose-dependent.
Animalsafter sucrose loading; dose-dependent
Magnesium hydroxide and aluminum hydroxide
no changein humans1
1 study
Magnesium hydroxide and aluminum hydroxide
no changein humans1
Magnesium hydroxide and aluminum hydroxide showed no clear effect on postprandial blood glucose in humans (co-administered with acarbose, after a 75 g sucrose load).
Human trialco-administered with acarbose, after a 75 g sucrose loadsuspensionblood10 ml4 daysmalesn = 24
Associations
6Binge drinking
upin humans1
1 study
Binge drinking
upin humans1
Binge drinking is associated with postprandial blood glucose in humans (Resistance-trained binge drinkers versus resistance-trained low alcohol consumers) (RTB 137.58±21.54 mg/dL versus RTL 103.83±19.82 mg/dL).
HumansResistance-trained binge drinkers versus resistance-trained low alcohol consumersfemales
Hunger
upin humans1
1 study
Hunger
upin humans1
Hunger is associated with postprandial blood glucose in humans.
Humans
Eating companions
downin humans1
1 study
Eating companions
downin humans1
Eating companions are associated with postprandial blood glucose in humans (than eating alone).
Humansthan eating alone
Cardiovascular disease
upin humans1
1 study
Cardiovascular disease
upin humans1
Postprandial blood glucose is associated with cardiovascular disease in humans.
Review
Diabetes mellitus
upin humans1
1 study
Diabetes mellitus
upin humans1
Postprandial blood glucose is associated with diabetes mellitus in humans.
Review
Functional capacity
upin humans1
1 study
Functional capacity
upin humans1
Postprandial blood glucose is associated with functional capacity in humans (older women with type 2 diabetes) (r = 0.37).
Human trialolder women with type 2 diabetes12 weeksfemales